The SLHN.SW stock trades at CHF841.60 pre-market on 11 Mar 2026 as investors position ahead of Swiss Life Holding AG’s earnings on 12 Mar 2026. This move follows a +1.64% intraday change and a volume of 62,806 shares. We focus on the upcoming report’s likely impact on the CHF24.01B market cap, the company’s EPS of 41.49, and dividend sustainability. The earnings release may shift consensus around valuation and near-term price targets for Swiss Life on the SIX exchange.
Earnings preview: SLHN.SW stock
Swiss Life reports on 12 Mar 2026; the key questions are profit mix and dividend outlook. Management commentary on technical provisions, investment returns and capital generation will drive the stock reaction.
Analysts will watch EPS and underlying operating cash flow versus the trailing EPS 41.49 and free cash flow per share 30.46. A beat could support a move toward the CHF933.53 yearly model target.
Valuation and financials: SLHN.SW stock
Swiss Life shows a market cap of CHF24,009,729,514, trailing PE 20.28 and book value per share 244.92. The company pays CHF35.00 dividend per share and yields about 4.16%.
Key ratios include P/B 3.51, return on equity 12.52%, and debt-to-equity 1.56. These metrics place Swiss Life above some sector peers on price multiples but with a premium to book that demands steady earnings.
Technicals and trading: SLHN.SW stock
Pre-market price is CHF841.60 with a day range CHF838.40–CHF849.20 and 50/200-day averages of CHF867.63 and CHF857.02. Momentum indicators are cautious: RSI 36.36 and MACD histogram negative.
Bollinger bands are 823.62–890.64. The technical picture favors buyers on a solid earnings beat, but the current trend shows short-term weakness versus moving averages.
Meyka grade & forecast: SLHN.SW stock
Meyka AI rates SLHN.SW with a score out of 100: 67.16 | Grade B | Suggestion: HOLD. This grade factors in S&P 500 and sector comparisons, financial growth, key metrics, forecasts, and analyst signals. Grades are informational and not financial advice.
Meyka AI’s forecast model projects monthly CHF845.57, quarterly CHF961.70, and yearly CHF933.53 versus the current CHF841.60. The yearly projection implies an upside of 10.92%, and the quarterly model implies 14.28%. Forecasts are model-based projections and not guarantees.
Risks and catalysts: SLHN.SW stock
Immediate catalysts include the earnings release, dividend confirmation, and any capital management update. A strong capital generation print could support dividends and buybacks.
Risks include weaker investment returns, higher interest expense, and regulatory shifts in pension rules. The companyRating dated 10 Mar 2026 shows a C (Sell) signal from one data set, highlighting mixed analyst signals.
Sector context and market outlook: SLHN.SW stock
Swiss Life sits in the Switzerland Financial Services sector, which is down -5.52% over 3 months and -7.06% YTD. The sector average PE is 17.43, while Swiss Life trades at a premium on price-to-book.
A resilient Swiss economy and steady insurance flows would support valuation; conversely, sector weakness may limit upside despite company-specific strength.
Final Thoughts
Key takeaways: SLHN.SW stock trades at CHF841.60 pre-market on 11 Mar 2026 as investors await Swiss Life’s earnings on 12 Mar 2026. Valuation is mixed: trailing PE 20.28 and P/B 3.51 sit above some sector peers while dividend yield near 4.16% underpins income interest. Technical indicators signal short-term caution with RSI 36.36 and price below the 50-day average. Meyka AI’s models project a yearly target CHF933.53 (implied upside 10.92%) and a quarterly target CHF961.70 (implied upside 14.28%). Our grade: Meyka AI rates SLHN.SW with a score out of 100 and assigns Grade B, Suggestion: HOLD. Watch the earnings release for guidance on investment returns and capital distribution; a clear beat should lift consensus price targets and validate the model upside. For live updates and deeper metrics, see the Swiss Life site source and the company image and data summary source. For a quick stock summary on our platform visit Meyka AI’s SLHN.SW page: https://meyka.ai/stocks/SLHN.SW
FAQs
When does Swiss Life report earnings and why does it matter for SLHN.SW stock?
Swiss Life reports on 12 Mar 2026. The results matter because earnings drive capital generation, dividend coverage and management guidance, which are the main levers for SLHN.SW stock moves on the SIX exchange.
What is Meyka AI’s view and forecast for SLHN.SW stock?
Meyka AI rates SLHN.SW 67.16 (Grade B, HOLD). The model projects CHF933.53 for the year (implied upside 10.92%) and a quarterly target CHF961.70. Forecasts are projections, not guarantees.
What are the main valuation metrics for Swiss Life?
Key metrics: price CHF841.60, EPS 41.49, PE 20.28, P/B 3.51, dividend per share CHF35.00 and yield ~4.16%. These show a premium to book but a solid income profile.
Which risks should investors watch heading into the earnings report?
Watch for weaker investment returns, higher claims or provisioning, and any negative capital adequacy commentary. Regulatory changes or a surprise dividend cut would be immediate negative catalysts.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.
What brings you to Meyka?
Pick what interests you most and we will get you started.
I'm here to read news
Find more articles like this one
I'm here to research stocks
Ask our AI about any stock
I'm here to track my Portfolio
Get daily updates and alerts (coming March 2026)